the republic logo

Switzerland's Roche sees 1st-half profit drop on franc strength, one-time effects; revenue up

bug
Share/Save/Bookmark

BERLIN — Drug maker Roche Holding AG says its first-half profit was weighed down by the surging Swiss franc and one-time effects, while solid sales of cancer treatments helped push revenue higher.

Roche, which reports earnings every six months, said Thursday that net income for the January-June period was 5.25 billion francs ($5.5 billion) — down 7 percent from 5.64 billion francs a year earlier.

Revenue rose 3 percent to 23.59 billion francs from 22.97 billion francs. Roche said it saw particularly strong increases in sales of breast cancer drugs.

Roche pointed to "the significant negative currency impact" as a factor in the drop in profit, along with factors such as the impact of recent acquisitions including that of InterMune, a developer of lung disease treatments.

Think your friends should see this? Share it with them!

Story copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Feedback, Corrections and Other Requests: AP welcomes feedback and comments from readers. Send an email to info@ap.org and it will be forwarded to the appropriate editor or reporter.


We also have more stories about:
(click the phrases to see a list)

Category:

Follow The Republic:

All content copyright ©2015 The Republic, a division of Home News Enterprises unless otherwise noted.
All rights reserved. Privacy policy.